Question 1

What are the potential side effects of MT-1303 compared to fingolimod?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase 1 Study to Explore the Cardiac Pharmacodynamics of MT-1303 clinical trial (NCT02193217). Contact the study team or your healthcare provider for specific answers.

Question 2

How will my heart health be monitored during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase 1 Study to Explore the Cardiac Pharmacodynamics of MT-1303 clinical trial (NCT02193217). Contact the study team or your healthcare provider for specific answers.

Question 3

What is the purpose of using a placebo in this study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase 1 Study to Explore the Cardiac Pharmacodynamics of MT-1303 clinical trial (NCT02193217). Contact the study team or your healthcare provider for specific answers.

Question 4

How might this trial impact my current treatment plan for multiple sclerosis?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase 1 Study to Explore the Cardiac Pharmacodynamics of MT-1303 clinical trial (NCT02193217). Contact the study team or your healthcare provider for specific answers.

Question 5

What should I expect during the study visits?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase 1 Study to Explore the Cardiac Pharmacodynamics of MT-1303 clinical trial (NCT02193217). Contact the study team or your healthcare provider for specific answers.

What this study is about